Intellipharmaceutics International Inc. (IPCI)

[fabius]

Armistice Capital up from 1636000 shares to 1816000 shares (or 5.2% of shares out)

Wim and Angelo, let's see if mr Boyd has better insights than ourself; it is a small bet for his fund, but that is the kind of guy who doesn't like losing money.
Let's see if he decides to increase again...likely he would then try to influence the BoD...he is an ACTIVIST by nature.

Regarding possible negotations: we know for sure that there is a legal procedure with Purdue, something which is by definition set up to find possible Agreement before the court gets the process in its full hands (Samsa, pls correct me if I am wrong). Likely insider buying it is not allowed during this period.

Regarding Rexista AdComm and filing: it is clear it was an ambush; FDA and IPCI already agreed a path towards intravenous approval. IPCI fault was: 1) not having a partner on its side, helping with the process and lobbying 2) not having a pharma lawyer at the AdComm 3) not having someone with presentation skills at the AdComm.

IPCI is currently a bunch of people with very low business acumen and even less financial markets dynamics comprehension.

But, there is a but...they still have 6-9 months to change/deliver on many fronts:
if that happens I would expect the market cap to be at least 100Mln, which could be reached via an Agreement with Purdue alone.
My expectations are right now pessimistics, but still has tiny hopes.